Apotex Drug Patent Portfolio
Apotex owns 3 orange book drugs protected by 24 US patents Given below is the list of Apotex's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10537520 | Stable liquid formulations of melphalan | 29 Jun, 2036 | Active |
| US6063927 | Paroxetine derivatives | 23 Oct, 2019 | Expired |
| US6063927 | Paroxetine derivatives | 23 Apr, 2019 | Expired |
| US6172233 | Process for making paroxetine | 15 Jul, 2018 | Expired |
| US6172233 | Process for making paroxetine | 15 Jan, 2018 | Expired |
| US6121291 | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder | 17 Sep, 2017 | Expired |
| US6121291 | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder | 17 Mar, 2017 | Expired |
| US6548084 | Controlled release compositions | 19 Jan, 2017 | Expired |
| US7229640 | Paroxetine controlled release compositions | 19 Jan, 2017 | Expired |
| US6548084 | Controlled release compositions | 19 Jul, 2016 | Expired |
| US7229640 | Paroxetine controlled release compositions | 19 Jul, 2016 | Expired |
| US5811436 | Oral liquid compositions containing paroxetine resinate | 22 Mar, 2016 | Expired |
| US5872132 | Form of paroxetine hydrochloride anhydrate | 19 Nov, 2015 | Expired |
| US5900423 | Form of paroxetine hydrochloride anhydrate | 19 Nov, 2015 | Expired |
| US6080759 | Paroxetine hydrochloride form A | 19 Nov, 2015 | Expired |
| US6133289 | Paroxetine hydrochloride form A or C | 19 Nov, 2015 | Expired |
| US5811436 | Oral liquid compositions containing paroxetine resinate | 22 Sep, 2015 | Expired |
| US6113944 | Paroxetine tablets and process to prepare them | 14 Jun, 2015 | Expired |
| US5872132 | Form of paroxetine hydrochloride anhydrate | 19 May, 2015 | Expired |
| US5900423 | Form of paroxetine hydrochloride anhydrate | 19 May, 2015 | Expired |
| US6080759 | Paroxetine hydrochloride form A | 19 May, 2015 | Expired |
| US6133289 | Paroxetine hydrochloride form A or C | 19 May, 2015 | Expired |
| US6113944 | Paroxetine tablets and process to prepare them | 14 Dec, 2014 | Expired |
| US5422123 | Tablets with controlled-rate release of active substances | 06 Dec, 2012 | Expired |
Latest Legal Activities on Apotex's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Apotex.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 15 Jul, 2019 | US7229640 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 28 Jan, 2019 | US7229640 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jun, 2007 | US7229640 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jun, 2007 | US7229640 (Litigated) |
|
Issue Notification Mailed
Critical
| 23 May, 2007 | US7229640 (Litigated) |
| Receipt into Pubs | 12 Apr, 2007 | US7229640 (Litigated) |
| Dispatch to FDC | 12 Apr, 2007 | US7229640 (Litigated) |
| Receipt into Pubs | 03 Apr, 2007 | US7229640 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 23 Feb, 2007 | US7229640 (Litigated) |
|
Mail Notice of Allowance
Critical
| 29 Dec, 2006 | US7229640 (Litigated) |
|
Notice of Allowance Data Verification Completed
Critical
| 27 Dec, 2006 | US7229640 (Litigated) |
|
Information Disclosure Statement (IDS) Filed
Critical
| 07 Dec, 2006 | US7229640 (Litigated) |
|
Information Disclosure Statement considered
Critical
| 07 Dec, 2006 | US7229640 (Litigated) |
| Date Forwarded to Examiner | 17 Oct, 2006 | US7229640 (Litigated) |
| Disposal for a RCE / CPA / R129 | 17 Oct, 2006 | US7229640 (Litigated) |
Apotex's Drug Patent Litigations
Apotex's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 25, 2004, against patent number US6063927. The petitioner , challenged the validity of this patent, with FRANCISCUS BERNARDUS GEMM BENNEKER et al as the respondent. Click below to track the latest information on how companies are challenging Apotex's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6063927 | May, 2004 |
Motion Decision
(25 May, 2004)
| FRANCISCUS BERNARDUS GEMM BENNEKER et al | |
Apotex's Family Patents
Apotex Drug List
Given below is the complete list of Apotex's drugs and the patents protecting them.
1. Ivra
Ivra is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10537520 | Stable liquid formulations of melphalan |
29 Jun, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ivra's drug page
2. Paxil
Paxil is protected by 18 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6063927
(Pediatric)
| Paroxetine derivatives |
23 Oct, 2019
(5 years ago)
| Expired |
| US6063927 | Paroxetine derivatives |
23 Apr, 2019
(5 years ago)
| Expired |
| US6172233
(Pediatric)
| Process for making paroxetine |
15 Jul, 2018
(6 years ago)
| Expired |
| US6172233 | Process for making paroxetine |
15 Jan, 2018
(6 years ago)
| Expired |
| US6121291
(Pediatric)
| Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
17 Sep, 2017
(7 years ago)
| Expired |
| US6121291 | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
17 Mar, 2017
(7 years ago)
| Expired |
| US5811436
(Pediatric)
| Oral liquid compositions containing paroxetine resinate |
22 Mar, 2016
(8 years ago)
| Expired |
| US5872132
(Pediatric)
| Form of paroxetine hydrochloride anhydrate |
19 Nov, 2015
(8 years ago)
| Expired |
| US5900423
(Pediatric)
| Form of paroxetine hydrochloride anhydrate |
19 Nov, 2015
(8 years ago)
| Expired |
| US6080759
(Pediatric)
| Paroxetine hydrochloride form A |
19 Nov, 2015
(8 years ago)
| Expired |
| US6133289
(Pediatric)
| Paroxetine hydrochloride form A or C |
19 Nov, 2015
(8 years ago)
| Expired |
| US5811436 | Oral liquid compositions containing paroxetine resinate |
22 Sep, 2015
(9 years ago)
| Expired |
| US6113944
(Pediatric)
| Paroxetine tablets and process to prepare them |
14 Jun, 2015
(9 years ago)
| Expired |
| US5872132 | Form of paroxetine hydrochloride anhydrate |
19 May, 2015
(9 years ago)
| Expired |
| US5900423 | Form of paroxetine hydrochloride anhydrate |
19 May, 2015
(9 years ago)
| Expired |
| US6080759 | Paroxetine hydrochloride form A |
19 May, 2015
(9 years ago)
| Expired |
| US6133289 | Paroxetine hydrochloride form A or C |
19 May, 2015
(9 years ago)
| Expired |
| US6113944 | Paroxetine tablets and process to prepare them |
14 Dec, 2014
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Paxil's drug page
3. Paxil Cr
Paxil Cr is protected by 13 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6121291
(Pediatric)
| Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
17 Sep, 2017
(7 years ago)
| Expired |
| US6121291 | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
17 Mar, 2017
(7 years ago)
| Expired |
| US6548084
(Pediatric)
| Controlled release compositions |
19 Jan, 2017
(7 years ago)
| Expired |
| US7229640
(Pediatric)
| Paroxetine controlled release compositions |
19 Jan, 2017
(7 years ago)
| Expired |
| US6548084 | Controlled release compositions |
19 Jul, 2016
(8 years ago)
| Expired |
| US7229640 | Paroxetine controlled release compositions |
19 Jul, 2016
(8 years ago)
| Expired |
| US5872132
(Pediatric)
| Form of paroxetine hydrochloride anhydrate |
19 Nov, 2015
(8 years ago)
| Expired |
| US5900423
(Pediatric)
| Form of paroxetine hydrochloride anhydrate |
19 Nov, 2015
(8 years ago)
| Expired |
| US6133289
(Pediatric)
| Paroxetine hydrochloride form A or C |
19 Nov, 2015
(8 years ago)
| Expired |
| US5872132 | Form of paroxetine hydrochloride anhydrate |
19 May, 2015
(9 years ago)
| Expired |
| US5900423 | Form of paroxetine hydrochloride anhydrate |
19 May, 2015
(9 years ago)
| Expired |
| US6133289 | Paroxetine hydrochloride form A or C |
19 May, 2015
(9 years ago)
| Expired |
| US5422123
(Pediatric)
| Tablets with controlled-rate release of active substances |
06 Dec, 2012
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Paxil Cr's drug page